comparemela.com

Latest Breaking News On - Kennedy capital management - Page 1 : comparemela.com

Voisard Asset Management Group Inc. Takes Position in VIZIO Holding Corp. (NYSE:VZIO)

Voisard Asset Management Group Inc. bought a new stake in VIZIO Holding Corp. (NYSE:VZIO – Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 21,715 shares of the company’s stock, valued at approximately $167,000. Several other institutional investors also recently modified […]

United-states
American
Roth-mkm
Adamr-townsend
William-wei-wang
Craig-hallum
Piper-sandler
American-century-companies-inc
Securities-exchange-commission
Corient-private-wealth
Voisard-asset-management-group-inc
Exchange-commission

UMH Properties (NYSE:UMH) Upgraded to Hold at StockNews.com

UMH Properties (NYSE:UMH – Get Free Report) was upgraded by equities research analysts at StockNews.com from a “sell” rating to a “hold” rating in a note issued to investors on Wednesday. Other equities analysts also recently issued reports about the company. Wedbush reissued a “neutral” rating and set a $17.00 target price on shares of […]

New-jersey
United-states
Maryland
Alabama
South-carolina
Pennsylvania
Michigan
Georgia
New-york
Tennessee
Indiana
Ohio

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX) Insider Sells $121,183.87 in Stock

Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Free Report) insider Carmen Jeffrey Del sold 7,541 shares of the company’s stock in a transaction on Friday, June 7th. The stock was sold at an average price of $16.07, for a total transaction of $121,183.87. Following the completion of the sale, the insider now owns 18,427 shares of […]

Boston
Massachusetts
United-states
Kennedy-capital-management
Catalyst-pharmaceuticals-stock-performance
Vanguard-group-inc
Cantor-fitzgerald
Nasdaq
Institutional-investors-weigh-in-on-catalyst-pharmaceuticals
Quarter-for-catalyst-pharmaceuticals
Janus-henderson-group

StockNews.com Downgrades Evans Bancorp (NYSEAMERICAN:EVBN) to Sell

Evans Bancorp (NYSEAMERICAN:EVBN – Get Free Report) was downgraded by stock analysts at StockNews.com from a “hold” rating to a “sell” rating in a research report issued on Tuesday. Separately, Piper Sandler dropped their price objective on shares of Evans Bancorp from $30.00 to $27.00 and set a “neutral” rating on the stock in a […]

United-states
Piper-sandler
Johnb-connerton
News-ratings-for-evans-bancorp-daily
Pl-capital-advisors-llc
Evans-bancorp
Evans-bancorp-stock-performance
Capital-investment-advisors
Securities-exchange-commission
Evans-bancorp-inc
Hedge-funds-weigh-in-on-evans-bancorp
Vanguard-group-inc

Bioventus (NYSE:BVS) Hits New 12-Month High at $7.02

Bioventus Inc. (NYSE:BVS – Get Free Report) shares reached a new 52-week high on Wednesday . The company traded as high as $7.02 and last traded at $7.00, with a volume of 167415 shares. The stock had previously closed at $6.53. Analyst Upgrades and Downgrades Several brokerages recently weighed in on BVS. Canaccord Genuity Group […]

United-states
Craig-hallum
Mark-leonard-singleton
Citigroup-inc
Barclays-plc
Bailard-inc
Canaccord-genuity-group
Securities-exchange-commission
York-mellon-corp
Bioventus-inc
Kennedy-capital-management
Get-free-report

vimarsana © 2020. All Rights Reserved.